InvestorsHub Logo

that_little_voice

05/13/21 11:54 AM

#165075 RE: calstang66 #165024

Just like when the CEO of Samsung called to congratulate on the data. I am amazed how people don't see their game anymore. No revenue or EUA so let's PR about A NON RECOURSE DEAL WITH INDIA AND GLOSS OVER THE FACT THAT NOTHING HAPPENS UNLESS DRUG IS APPROVED. Also, he brags this got done in 4 days? In what world is that a good sign? Who doesn't take their time on the details especially since nothing is happening until approval? Another Mexico, china etc.

stockorus

05/13/21 12:30 PM

#165083 RE: calstang66 #165024

Their focus is on "therapeutics" and we are a potentially key therapeutic for Covid critical and LH; likely their research team saw our potential in their preferred space and grabbed the opportunity:

"Our vision is to become a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs." "We are renowned for our expertise across varied therapies such as antituberculars, antimalarials, antiretrovirals, antibacterials, antidiabetics, antihypertensives and antiasthmatics."

Anybody know how "Big Pharma" this company is in India? The more their power and access in the Indian medical scene, the better our chances. For example, if Dr. Reddy's Labs became our partner, I would be thrilled because in my mind they are Big Pharma there with big clout. No clue about Macleods.